Risk of a lamotrigine-related skin rash: Current meta-analysis and postmarketing cohort analysis

Seizure

Volumn 25, Issue , 2015, Pages 52-61

  Wang, Xiang Qing ^a   Xiong, Jiang ^a   Xu, Wen Huan ^a   Yu, Sheng Yuan ^a   Huang, Xu Sheng ^a   Zhang, Jia Tang ^a   Tian, Cheng Lin ^a   Huang, De Hui ^a   Jia, Wei Quan ^a   Lang, Sen Yang ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Incidence; Lamotrigine; Meta analysis; Prospective study; Rash

Indexed keywords

LAMOTRIGINE; LITHIUM; PLACEBO; ANTICONVULSIVE AGENT; TRIAZINE DERIVATIVE;

ADVERSE OUTCOME; ARTICLE; CLINICAL EVALUATION; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; COMPARATIVE STUDY; DATA BASE; DRUG ERUPTION; HUMAN; INCIDENCE; MEDLINE; META ANALYSIS; PATIENT RISK; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCOPUS; SKIN MANIFESTATION; SYSTEMATIC REVIEW; TREATMENT DURATION; CHEMICALLY INDUCED; DRUG ERUPTIONS; EXANTHEMA; RISK;

ANTICONVULSANTS; DRUG ERUPTIONS; EXANTHEMA; HUMANS; INCIDENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK; TRIAZINES;

EID: 84923223745     PISSN: 10591311     EISSN: 15322688     Source Type: Journal    
DOI: 10.1016/j.seizure.2014.12.001     Document Type: Article

References (57)

1. J.G. Reid, M.J. Gitlin, and L.L. Altshuler Lamotrigine in psychiatric disorders J Clin Psychiatry 74 7 2013 675 684
2. C.T. Clark, A.M. Klein, J.M. Perel, J. Helsel, and K.L. Wisner Lamotrigine dosing for pregnant patients with bipolar disorder Am J Psychiatry 170 11 2013 1240 1247
3. N. Brix Finnerup, S. Hein Sindrup, and T. Staehelin Jensen Management of painful neuropathies Handb Clin Neurol 115 2013 279 290
4. D.R. Yarbrough 3rd. Experience with toxic epidermal necrolysis treated in a burn center J Burn Care Rehabil 17 1 1996 30 33
5. M. Mockenhaupt, J. Messenheimer, P. Tennis, and J. Schlingmann Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics Neurology 64 7 2005 1134 1138
6. J.R. Calabrese, J.R. Sullivan, C.L. Bowden, T. Suppes, J.F. Goldberg, and G.S. Sachs Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management J Clin Psychiatry 63 11 2002 1012 1019
7. N. Mantel, and W. Haenszel Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 22 4 1959 719 748
8. R. DerSimonian, and R. Kacker Random-effects model for meta-analysis of clinical trials: an update Contemp Clin Trials 28 2 2007 105 114
9. E. Zintzaras, and J.P. Ioannidis Heterogeneity testing in meta-analysis of genome searches Genet Epidemiol 28 2 2005 123 137
10. J. Lau, J.P. Ioannidis, and C.H. Schmid Quantitative synthesis in systematic reviews Ann Intern Med 127 9 1997 820 826
11. T.J. Steiner, L.J. Findley, and A.W. Yuen Lamotrigine versus placebo in the prophylaxis of migraine with and without aura Cephalalgia 17 2 1997 109 112
12. R. Kapoor, J. Furby, T. Hayton, K.J. Smith, D.R. Altmann, and R. Brenner Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomized, double-blind, placebo-controlled, parallel-group trial Lancet Neurol 9 7 2010 681 688
13. D.M. Simpson, J.C. McArthur, R. Olney, D. Clifford, Y. So, and D. Ross Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial Neurology 60 9 2003 1508 1514
14. A.I. Vinik, M. Tuchman, B. Safirstein, C. Corder, L. Kirby, and K. Wilks Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies Pain 128 1-2 2007 169 179
15. J. Messenheimer, R.E. Ramsay, L.J. Willmore, R.F. Leroy, J.J. Zielinski, and R. Mattson Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial Epilepsia 35 1 1994 113 121
16. J. Motte, E. Trevathan, J.F. Arvidsson, M.N. Barrera, E.L. Mullens, and P. Manasco Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome N Engl J Med 337 25 1997 1807 1812
17. M.L. van der Loos, P. Mulder, E.G. Hartong, M.B. Blom, A.C. Vergouwen, and M.S. van Noorden Efficacy and safety of two treatment algorithms in bipolar depression consisting of a combination of lithium, lamotrigine or placebo and paroxetine Acta Psychiatr Scand 122 3 2010 246 254
18. J.R. Calabrese, C.L. Bowden, G.S. Sachs, J.A. Ascher, E. Monaghan, and G.D. Rudd A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression J Clin Psychiatry 60 2 1999 79 88
19. J.R. Calabrese, C.L. Bowden, G. Sachs, L.N. Yatham, K. Behnke, and O.P. Mehtonen A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder J Clin Psychiatry 64 9 2003 1013 1024
20. C. Normann, B. Hummel, L.O. Schärer, M. Hörn, H. Grunze, and J. Walden Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study J Clin Psychiatry 63 4 2002 337 344
21. C.L. Bowden, J.R. Calabrese, G. Sachs, L.N. Yatham, S.A. Asghar, and M. Hompland A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder Arch Gen Psychiatry 60 4 2003 392 400
22. M. Sajatovic, L. Gyulai, J.R. Calabrese, T.R. Thompson, B.G. Wilson, and R. White Maintenance treatment outcomes in older patients with bipolar I disorder Am J Geriatr Psychiatry 13 4 2005 305 311
23. M. Reunanen, M. Dam, and A.W. Yuen A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy Epilepsy Res 23 2 1996 149 155
24. M.J. Brodie, A. Richens, and A.W. Yuen Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group Lancet 345 8948 1995 476 479
25. M.J. Brodie, P.W. Overstall, and L. Giorgi Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group Epilepsy Res 37 1 1999 81 87
26. K. Zeng, X. Wang, Z. Xi, and Y. Yan Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients Clin Neurol Neurosurg 112 4 2010 291 295
27. F. Gilliam, B. Vazquez, J.C. Sackellares, G.Y. Chang, J. Messenheimer, and J. Nyberg An active-control trial of lamotrigine monotherapy for partial seizures Neurology 51 4 1998 1018 1025
28. T.J. Steiner, C.I. Dellaportas, L.J. Findley, M. Gross, F.B. Gibberd, and G.D. Perkin Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin Epilepsia 40 5 1999 601 607
29. D.M. Labiner, A.B. Ettinger, T.A. Fakhoury, S.S. Chung, B. Shneker, and W.O. Tatum Iv Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy Epilepsia 50 5 2009 434 442
30. G. Kluger, K. Berz, and H. Holthausen The long-term use of vigabatrin and lamotrigine in patients with severe childhood onset epilepsy Eur J Paediatr Neurol 5 1 2001 37 40
31. R.W. Licht, J.N. Nielsen, L.F. Gram, P. Vestergaard, and H. Bendz Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice. The 6th trial of the Danish University Antidepressant Group (DUAG-6) Bipolar Disord 12 5 2010 483 493
32. E.B. Brown, S.L. McElroy, P.E. Keck Jr., A. Deldar, D.H. Adams, and M. Tohen A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression J Clin Psychiatry 67 7 2006 1025 1033
33. M.J. Brodie, and A.W. Yuen Lamotrigine substitution study: evidence for synergism with sodium valproate' 105 Study Group Epilepsy Res 26 3 1997 423 432
34. K. Farrell, M.B. Connolly, R. Munn, S. Peng, and L.M. MacWilliam Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy Pediatr Neurol 16 3 1997 201 205
35. J.R. Calabrese, C.L. Bowden, S.L. McElroy, J. Cookson, J. Andersen, and P.E. Keck Jr. Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder Am J Psychiatry 156 7 1999 1019 1023
36. E. Beghi, G. Gatti, C. Tonini, E. Ben-Menachem, D.W. Chadwick, and M. Nikanorova Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controlled trial Epilepsy Res 57 1 2003 1 13
37. X.Q. Wang, S.Y. Lang, X.B. Shi, H.J. Tian, R.F. Wang, and F. Yang Antiepileptic drug-induced skin reactions: a retrospective study and analysis in 3793 Chinese patients with epilepsy Clin Neurol Neurosurg 114 7 2012 862 865
38. S. Chung, N. Wang, and N. Hank Comparative retention rates and long-term tolerability of new antiepileptic drugs Seizure 16 4 2007 296 304
39. H. Arif, R. Buchsbaum, D. Weintraub, S. Koyfman, C. Salas-Humara, and C.W. Bazil Comparison and predictors of rash associated with 15 antiepileptic drugs Neurology 68 20 2007 1701 1709
40. L.J. Hirsch, H. Arif, E.A. Nahm, R. Buchsbaum, S.R. Resor Jr., and C.W. Bazil Cross-sensitivity of skin rashes with antiepileptic drug use Neurology 71 19 2008 1527 1534
41. S. Alvestad, S. Lydersen, and E. Brodtkorb Influence by gender, age, and learning disability Epilepsia 48 7 2007 1360 1365
42. Y. Mogami, Y. Takahashi, R. Takayama, H. Ohtani, H. Ikeda, and K. Imai Cutaneous adverse drug reaction in patients with epilepsy after acute encephalitis Brain Dev 34 6 2012 496 503
43. T. Shechter, Z. Shorer, U. Kramer, T. Lerman-Sagie, E. Ronen, and R. Rotem Adverse reactions of topiramate and lamotrigine in children Pharmacoepidemiol Drug Saf 14 3 2005 187 192
44. D.G. McDonald, Y. Najam, M.B. Keegan, M. Whooley, D. Madden, and J.B. McMenamin The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood Seizure 14 2 2005 112 116
45. F.J. Mackay, L.V. Wilton, G.L. Pearce, S.N. Freemantle, and R.D. Mann Safety of long-term lamotrigine in epilepsy Epilepsia 38 8 1997 881 886
46. I.C. Wong, G.E. Mawer, and J.W. Sander Adverse event monitoring in lamotrigine patients: a pharmacoepidemiologic study in the United Kingdom Epilepsia 42 2001 237 244
47. N.V. Acharya, R.M. Pickering, L.W. Wilton, and S.A. Shakir The safety and effectiveness of newer antiepileptics: a comparative postmarketing cohort study J Clin Pharmacol 45 4 2005 385 393
48. M.L. Iorio, U. Moretti, S. Colcera, L. Magro, I. Meneghelli, and D. Motola Use and safety profile of antiepileptic drugs in Italy Eur J Clin Pharmacol 63 4 2007 409 415
49. C. Lange-Asschenfeldt, R. Grohmann, B. Lange-Asschenfeldt, R.R. Engel, E. Rüther, and J. Cordes Cutaneous adverse reactions to psychotropic drugs: data from a multicenter surveillance program J Clin Psychiatry 70 9 2009 1258 1265
50. B. Aurich-Barrera, L. Wilton, D. Brown, and S. Shakir Paediatric postmarketing pharmacovigilance using prescription-event monitoring: comparison of the adverse event profiles of lamotrigine prescribed to children and adults in England Drug Saf 33 9 2010 751 763
51. S.M. Wallerstedt, G. Brunlöf, and A. Sundström Rates of spontaneous reports of adverse drug reactions for drugs reported in children: a cross-sectional study with data from the Swedish adverse drug reaction database and the Swedish Prescribed Drug Register Drug Saf 34 8 2011 669 682
52. P. Manasco, L. Mullens, and F. Matsuo Skin rash associated with Lamictal: incidence, time to onset and risk factors Epilepsia 37 Suppl. 5 1996 S164
53. A.H. Guberman Lamotrigine-associated rash risk/benefit considerations in adults and children Epilepsia 40 4 1999 985 991
54. R.D. Mann Prescription-event monitoring recent progress and future horizons Br J Clin Pharmacol 46 3 1998 195 201
55. D. Layton, G.L. Pearce, and S.A.W. Shakir Safety profile of tolterodine as used in general practice in England: results of prescription-event monitoring Drug Saf 24 9 2001 703 713
56. K. Aouam, H. BelHadj Ali, M. Youssef, A. Chaabane, M. Amri, and N.A. Boughattas Carbamazepine-induced DRESS and HHV6 primary infection: the importance of skin tests Epilepsia 49 9 2008 1630 1633
57. X.Q. Wang, X.B. Shi, R. Au, F.S. Chen, F. Wang, and S.Y. Lang Influence of chemical structure on skin reactions induced by antiepileptic drugs - the role of the aromatic ring Epilepsy Res 94 3 2011 213 217